688062.SH
迈威生物-U
SSE · Healthcare · Biotechnology · CN
CNY 29.23
−6.22%Margins
Gross margin
88.6%
EBITDA margin
-103.0%
EBIT margin
-121.2%
Net margin
-123.4%
FCF margin
-63.7%
-860.9%
Return on equity
-20.1%
Return on assets
-35.9%
Return on invested capital
0.16x
Asset turnover
-CNY 307.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026